GSK vs TPH · P/E 13, $103.31B cap vs P/E 7.1, rev $4.49B
GlaxoSmithKline PLC ADR (GSK) versus TRI Pointe Homes Inc (TPH) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
TRI Pointe Homes Inc (TPH) is a residential construction company listed on US.
GSK does not have a complete income-statement cache yet.
Latest reported TPH revenue for 2024-12-31 was $4.49B. Net income was $458.0M. Revenue was up 20.9% from 2023-12-31 to 2024-12-31. TPH currently screens at market cap $2.90B and trailing P/E 7.1.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. TPH currently screens at market cap $2.90B and trailing P/E 7.1.
Not investment advice. Open the GSK and TPH stock pages for the full models.
Not investment advice.